The Economics of Genomic Medicine:

Workshop Summary (2013)

Overview
Table of Contents
Related Resources

Authors

Adam C. Berger and Steve Olson, Rapporteurs; Roundtable on Translating Genomic-Based Research for Health; Board on Health Sciences Policy (HSP); Institute of Medicine (IOM)

Description

The sequencing of the human genome and the identification of links between specific genetic variants and diseases have led to tremendous excitement over the potential of genomics to direct patient treatment toward more effective or less harmful interventions. Still, the use of whole genome sequencing challenges the traditional model of medical care where a test is ordered only when there is a clear indication for its use and a path for downstream clinical action is known. This has created a tension between experts who contend that using this information is premature and those who believe that having such information will empower health care

[...]

Suggested Citation

Institute of Medicine. The Economics of Genomic Medicine: Workshop Summary. Washington, DC: The National Academies Press, 2013.

Import this citation to:

BibteX EndNote Reference Manager

ALSO OF INTEREST

Refining Processes for the Co-Development of Genome-Based Therapeutics and Companion Diagnostic Tests: Workshop Summary (2014)
Sarah H. Beachy, Samuel G. Johnson, Steve Olson, and Adam C. Berger, Rapporteurs; Roundtable on Translating Genomic-Based Research for Health; Board on Health Sciences Policy; Institute of Medicine

Genome-Based Diagnostics: Clarifying Pathways to Clinical Use: Workshop Summary (2012)
Steve Olson and Adam C. Berger, Rapporteurs; Roundtable on Translating Genomic-Based Research for Health; Board on Health Sciences Policy; Institute of Medicine

Integrating Large-Scale Genomic Information into Clinical Practice: Workshop Summary (2012)
Steve Olson, Sarah H. Beachy, Claire F. Giammaria, and Adam C. Berger, Rapporteurs; Roundtable on Translating Genomic-Based Research for Health; Institute of Medicine